Rapid Micro Biosystems (NASDAQ:RPID) Shares Down 2.6% - Here's What Happened

Key Points

• Shares of Rapid Micro Biosystems (NASDAQ: RPID) fell by 2.6% on Monday, trading between $3.45 and $3.69, with a trading volume that was significantly higher than average.
• The company reported a loss of $0.27 EPS for the recent quarter, slightly missing analysts' estimates, while revenue exceeded expectations at $7.26 million.
• Analyst ratings for Rapid Micro Biosystems are mixed, with an average rating of "Moderate Buy" and a consensus price target of $8.00 from multiple analysts.

Shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report) traded down 2.6% during mid-day trading on Monday . The company traded as low as $3.45 and last traded at $3.69. 207,451 shares were traded during trading, an increase of 191% from the average session volume of 71,369 shares. The stock had previously closed at $3.79.

Analyst Ratings Changes

Several equities analysts recently issued reports on RPID shares. Lake Street Capital assumed coverage on Rapid Micro Biosystems in a report on Monday, July 28th. They set a "buy" rating and a $8.00 price objective for the company. Weiss Ratings restated a "sell (d-)" rating on shares of Rapid Micro Biosystems in a research report on Saturday, September 27th. Finally, Wall Street Zen upgraded shares of Rapid Micro Biosystems from a "sell" rating to a "hold" rating in a research report on Saturday, September 13th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Rapid Micro Biosystems currently has an average rating of "Moderate Buy" and a consensus target price of $8.00.

Rapid Micro Biosystems Stock Down 2.6%

The company has a market capitalization of $163.13 million, a price-to-earnings ratio of -3.65 and a beta of 1.38. The stock has a fifty day moving average price of $3.03 and a two-hundred day moving average price of $3.02.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last released its earnings results on Tuesday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.01). The firm had revenue of $7.26 million during the quarter, compared to analysts' expectations of $7.10 million. Rapid Micro Biosystems had a negative net margin of 145.63% and a negative return on equity of 63.07%. Rapid Micro Biosystems has set its FY 2025 guidance at EPS. As a group, research analysts forecast that Rapid Micro Biosystems, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Transactions at Rapid Micro Biosystems

In other Rapid Micro Biosystems news, CEO Robert G. Jr. Spignesi sold 11,881 shares of Rapid Micro Biosystems stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $3.32, for a total value of $39,444.92. Following the completion of the sale, the chief executive officer directly owned 970,550 shares of the company's stock, valued at approximately $3,222,226. The trade was a 1.21% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 46,619 shares of company stock worth $157,960 in the last quarter. 29.96% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Rapid Micro Biosystems

Institutional investors have recently added to or reduced their stakes in the business. ABG WTT Global Life Science Capital Partners GP Ltd lifted its position in Rapid Micro Biosystems by 78.0% during the first quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock worth $4,880,000 after buying an additional 810,000 shares during the period. Parkman Healthcare Partners LLC acquired a new stake in shares of Rapid Micro Biosystems in the first quarter worth approximately $1,942,000. Geode Capital Management LLC grew its holdings in Rapid Micro Biosystems by 1.6% in the second quarter. Geode Capital Management LLC now owns 204,079 shares of the company's stock valued at $704,000 after purchasing an additional 3,143 shares during the period. Informed Momentum Co LLC acquired a new position in Rapid Micro Biosystems during the first quarter worth approximately $467,000. Finally, Evernest Financial Advisors LLC purchased a new position in Rapid Micro Biosystems during the first quarter worth approximately $347,000. 52.60% of the stock is currently owned by institutional investors and hedge funds.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.